Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders

被引：12

作者：

Moraca, Federica ^{[1
,2
]}

Marzano, Simona ^{[1
]}

D'Amico, Francesco ^{[3
]}

Lupia, Antonio ^{[1
,2
]}

Di Fonzo, Silvia ^{[3
]}

Vertecchi, Eleonora ^{[4
]}

Salvati, Erica ^{[4
]}

Di Porzio, Anna ^{[1
]}

Catalanotti, Bruno ^{[1
]}

Randazzo, Antonio ^{[1
]}

Pagano, Bruno ^{[1
]}

Amato, Jussara ^{[1
]}

机构：

[1] Univ Naples Federico II, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy

[2] Univ Magna Groecia Catanzaro, Net4Sci Srl, I-88100 Catanzaro, Italy

[3] Elettra Sincrotrone Trieste SCPA, Sci Pk, I-34149 Trieste, Italy

[4] CNR, Inst Mol Biol & Pathol, Via Apuli 4, I-00185 Rome, Italy

来源：

CHEMICAL COMMUNICATIONS | 2022年 / 58卷 / 85期

关键词：

COVID-19; DNA;

D O I：

10.1039/d2cc03135c

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The single-stranded RNA genome of SARS-CoV-2 contains some G-quadruplex-forming G-rich elements which are putative drug targets. Here, we performed a ligand-based pharmacophore virtual screening of FDA approved drugs to find candidates targeting such RNA structures. Further in silico and in vitro assays identified three drugs as emerging SARS-CoV-2 RNA G-quadruplex binders.

引用

页码：11913 / 11916

页数：5

共 50 条

[41] Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
Rampogu, Shailima
Lee, Keun Woo
FRONTIERS IN CHEMISTRY, 2021, 9
[42] Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
Sarkar, Arighna
Mandal, Kalyaneswar
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (44) : 23492 - 23494
[43] Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
Mslati, Hazem
Gentile, Francesco
Perez, Carl
Cherkasov, Artem
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (08) : 3771 - 3788
[44] Anti-HIV drug repurposing against SARS-CoV-2
Sang, Peng
Tian, Shu-Hui
Meng, Zhao-Hui
Yang, Li-Quan
RSC ADVANCES, 2020, 10 (27) : 15775 - 15783
[45] Identification of SARS-CoV-2 inhibitors through phylogenetics and drug repurposing
Anamika Mishra
Viswajit Mulpuru
Nidhi Mishra
Structural Chemistry, 2022, 33 : 1789 - 1797
[46] Identification of SARS-CoV-2 inhibitors through phylogenetics and drug repurposing
Mishra, Anamika
Mulpuru, Viswajit
Mishra, Nidhi
STRUCTURAL CHEMISTRY, 2022, 33 (05) : 1789 - 1797
[47] Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome
Bogacheva, Mariia S.
Kuivanen, Suvi
Potdar, Swapnil
Hassinen, Antti
Huuskonen, Sini
Pohner, Ina
Luck, Tamara J.
Turunen, Laura
Feodoroff, Michaela
Szirovicza, Leonora
Savijoki, Kirsi
Saarela, Jani
Tammela, Paivi
Paavolainen, Lassi
Poso, Antti
Varjosalo, Markku
Kallioniemi, Olli
Pietiainen, Vilja
Vapalahti, Olli
ANTIVIRAL RESEARCH, 2024, 223
[48] Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor
Ma, Chunlong
Hu, Yanmei
Wang, Yuyin
Choza, Juliana
Wang, Jun
ACS INFECTIOUS DISEASES, 2022, 8 (05): : 1022 - 1030
[49] Drug repurposing against SARS-CoV-2 using computational approaches
Kumar, Sumit
Kovalenko, Svitlana
Bhardwaj, Shakshi
Sethi, Aaftaab
Gorobets, Nikolay Yu.
Desenko, Sergey M.
Poonam
Rathi, Brijesh
DRUG DISCOVERY TODAY, 2022, 27 (07) : 2015 - 2027
[50] Computational guided approach for drug repurposing against SARS-CoV-2
Anand, Jigisha
Ghildiyal, Tanmay
Madhwal, Aakanksha
Bhatt, Rishabh
Verma, Devvret
Rai, Nishant
FUTURE VIROLOGY, 2021, 16 (03) : 211 - 243

← 1 2 3 4 5 →